Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Baxter
Boehringer Ingelheim
Johnson and Johnson
McKesson

Generated: March 21, 2019

DrugPatentWatch Database Preview

VEINAMINE 8% Drug Profile

« Back to Dashboard

When do Veinamine 8% patents expire, and when can generic versions of Veinamine 8% launch?

Veinamine 8% is a drug marketed by Hospira Inc and is included in one NDA.

The generic ingredient in VEINAMINE 8% is amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate profile page.

Summary for VEINAMINE 8%
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:VEINAMINE 8% at DailyMed
Drug patent expirations by year for VEINAMINE 8%

US Patents and Regulatory Information for VEINAMINE 8%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc VEINAMINE 8% amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate INJECTABLE;INJECTION 017957-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
QuintilesIMS
Merck
Johnson and Johnson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.